The EGFR/extracellular signal-regulated kinase (ERK) pathway leads to tumour cell proliferation, survival and chemotherapy resistance, and it is induced by PTX, and inhibited by MicroRNA-7 (miR-7) by downregulating EGFR expression. Here, EGFR is linked to neoplasm.